Procine recombinant NK-lysin inhibits hepatocellular carcinoma metastasis by downregulating FKBP3 and inhibiting oxidative phosphorylation and glycolysis: a proteomic analysis.
10.12122/j.issn.1673-4254.2023.07.08
- Author:
Yifan FAN
1
;
Zhiwei FENG
1
;
Kuohai FAN
1
;
Wei YIN
1
;
Na SUN
1
;
Panpan SUN
1
;
Yaogui SUN
1
;
Hongquan LI
1
Author Information
1. College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030801, China.
- Publication Type:Journal Article
- Keywords:
differentially expressed proteins;
hepatocellular carcinoma;
porcine recombinant NK-lysin;
proteomics
- MeSH:
Animals;
Swine;
Carcinoma, Hepatocellular/pathology*;
Liver Neoplasms/pathology*;
Oxidative Phosphorylation;
Proteomics;
Glycolysis;
RNA, Messenger
- From:
Journal of Southern Medical University
2023;43(7):1116-1126
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the potential mechanisms that mediate the inhibitory effect of porcine recombinant NKlysin (prNK-lysin) against liver cancer cell metastasis.
METHODS:HPLC-tandem mass spectrometry was used to identify the differentially expressed proteins in prNK-lysin-treated hepatocellular carcinoma SMMOL/LC-7721 cells in comparison with the control and PBS-treated cells. GO functional annotation and KEGG pathway analysis of the differentially expressed proteins were performed using GO and KEGG databases. RT-qPCR was used to determine the mRNA expression levels of polypeptide-N-acetylgalactosaminotransferase 13 (GALNT13), transmembrane protein 51 (TMEM51) and FKBP prolyl isomerase 3 (FKBP3) in the cells, and the protein expression of FKBP3 was verified using Western blotting.
RESULTS:Proteomic analysis identified 1989 differentially expressed proteins in prNK-lysin-treated cells compared with the control cells, and 2753 compared with PBS-treated cells. Fifteen proteins were differentially expressed between PBS-treated and the control cells, and 1909 were differentially expressed in prNK- lysin group compared with both PBS and control groups. These differentially expressed proteins were involved mainly in the viral process, translational initiation and RNA binding and were enriched mainly in ribosome, protein process in endoplasmic reticulum, and RNA transport pathways. RT-qPCR showed that compared with the control group, prNK-lysin treatment significantly increased the mRNA expressions of GALNT13 (P < 0.05) and TMEM51 (P < 0.01) and lowered FKBP3 mRNA expression (P < 0.05). Western blotting also showed a significantly decreased expression of FKBP3 protein in prNK-lysin-treated cells (P < 0.001).
CONCLUSION:Treatment with prNK-lysin causes significant changes in protein expression profile of SMMOL/LC-7721 cells and inhibits hepatocellular carcinoma metastasis by downregulating FKBP3 protein and affecting the cellular oxidative phosphorylation and glycolysis pathways.
